Department of Pathology and Immunology, Washington University Medical School, St. Louis, MO, USA.
Prog Mol Biol Transl Sci. 2010;93:395-421. doi: 10.1016/S1877-1173(10)93017-2.
Heparin-induced thrombocytopenia (HIT) with thrombosis is the most severe side effect of heparin administration. HIT patients may die or have permanent sequelae, such as a stroke or limb amputation. Contaminated heparin is associated with anaphylactic reactions and deaths by activating the contact system. It is also associated with high incidence of HIT via a yet unknown mechanism. This chapter shows that: (1) the contact system can be activated by a variety of unrelated molecules; (2) kallikrein directly cuts prothrombin to generate functional thrombin through contact system activation; and (3) while heparin contaminants, oversulfated heparin by-product (OS-HB), induce thrombin generation in both normal and HIT patient plasmas through contact system activation, authentic heparin induces thrombin activities only in HIT patient plasmas containing autoantibodies against protein/heparin complex. These data suggest that the negatively charged IgG/protein/heparin or OS-HB complex activate the contact system and produce thrombin in human plasma and thrombin partially activates the platelets allowing subsequent platelet activation through IgG/Fc receptor II signaling. The newly discovered mechanism of heparin-induced thrombin activity could explain the increased incidence of HIT in patients exposed to contaminated heparin. Furthermore, the assays used in these studies would be valuable for HIT diagnosis, prevention, and treatment.
肝素诱导的血小板减少症(HIT)伴血栓形成是肝素给药最严重的副作用。HIT 患者可能会死亡或留下永久性后遗症,如中风或肢体截肢。受污染的肝素通过激活接触系统与过敏反应和死亡有关。它还通过未知的机制与 HIT 的高发病率有关。这一章表明:(1)接触系统可以被各种不相关的分子激活;(2)激肽释放酶通过接触系统的激活直接将凝血酶原切割成有功能的凝血酶;(3)虽然肝素污染物、过硫酸化肝素副产物(OS-HB)通过接触系统的激活在正常和 HIT 患者的血浆中诱导凝血酶生成,但真正的肝素仅在含有针对蛋白/肝素复合物的自身抗体的 HIT 患者的血浆中诱导凝血酶活性。这些数据表明,带负电荷的 IgG/蛋白/肝素或 OS-HB 复合物激活接触系统并在人血浆中产生凝血酶,凝血酶部分激活血小板,通过 IgG/Fc 受体 II 信号允许随后的血小板激活。肝素诱导的凝血酶活性的新发现机制可以解释接触受污染肝素的患者中 HIT 发生率的增加。此外,这些研究中使用的检测方法将对 HIT 的诊断、预防和治疗具有重要价值。
Prog Mol Biol Transl Sci. 2010
Clin Appl Thromb Hemost. 2010-5-11
Prog Mol Biol Transl Sci. 2010
Haematologica. 2000-1
Semin Thromb Hemost. 2004-6
G Ital Cardiol (Rome). 2006-10
J Assoc Physicians India. 2008-8
Hematol Oncol Clin North Am. 2007-2
Clin Med (Lond). 2022-5
Proc Natl Acad Sci U S A. 2021-1-19
Biomacromolecules. 2017-9-13